Everolimus plus exemestane for hormone-receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: overall survival results from BOLERO-2

✍ Scribed by Piccart, M.; Hortobagyi, G. N.; Campone, M.; Pritchard, K. I.; Lebrun, F.; Ito, Y.; Noguchi, S.; Perez, A.; Rugo, H. S.; Deleu, I.; Burris, H. A.; Provencher, L.; Neven, P.; Gnant, M.; Shtivelband, M.; Wu, C.; Fan, J.; Feng, W.; Taran, T.; Baselga, J.

• Book ID: 126575034
• Publisher: Oxford University Press
• Year: 2014
• Tongue: English
• Weight: 142 KB
• Volume: 25
• Category: Article
• ISSN: 0923-7534
• DOI: 10.1093/annonc/mdu456